X
NUVB icon

Xponance’s Nuvation Bio NUVB Stock Holding History

Xponance’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.5K Buy
22,035
+3,079
+16% +$17.2K ﹤0.01% 1577
2025
Q4 		$170K Sell
18,956
-458
-2% -$2.84K ﹤0.01% 1415
2025
Q3 		$71.8K Buy
19,414
+80
+0.4% +$218 ﹤0.01% 1463
2025
Q2 		$37.7K Buy
19,334
+6,207
+47% +$12.9K ﹤0.01% 1472
2025
Q1 		$23.1K Buy
13,127
+684
+5% +$1.56K ﹤0.01% 1419
2024
Q4 		$33.1K Buy
12,443
+1,092
+10% +$2.81K ﹤0.01% 1417
2024
Q3 		$26K Hold
11,351
– – ﹤0.01% 1373
2024
Q2 		$33.1K Buy
+11,351
New +$34.6K ﹤0.01% 1293

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Xponance's NUVB Position: Q1 2026 in Review

Xponance increased its Nuvation Bio (NUVB) stake by 16% in Q1 2026, buying an estimated $17.2K and bringing the position to 22,035 shares worth $94.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Xponance first reported a position in NUVB in Q2 2024 and has held it in 8 quarters since. The position peaked at $170K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Xponance held 22,035 shares of Nuvation Bio worth $94.5K as of Q1 2026.
  • Xponance bought 3,079 Nuvation Bio shares in Q1 2026, an estimated $17.2K.
  • Nuvation Bio made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1577 holding.
  • Xponance first reported a position in Nuvation Bio in Q2 2024 and has held it in 8 quarters since.
  • Xponance's Nuvation Bio position peaked at $170K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.